{"title":"ldl归因心血管疾病的全球趋势和社会人口差异:GBD 2021分析(1990-2021)","authors":"Rohan Raj , Ujjwal Mishra , Nikhil Jain , Kanishka Kumar Awasthi","doi":"10.1016/j.ahj.2025.07.047","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Elevated low-density lipoprotein (LDL) cholesterol is a major modifiable risk factor for cardiovascular disease (CVD). While global trends in LDL-attributable CVD have been previously reported, disparities across sociodemographic development levels remain insufficiently explored.</div></div><div><h3>Objective</h3><div>To assess global, regional, and SDI-specific trends in the CVD burden attributable to high LDL cholesterol from 1990 to 2021.</div></div><div><h3>Methods</h3><div>We utilized Global Burden of Disease (GBD) 2021 data to evaluate CVD mortality and disability-adjusted life years (DALYs) attributable to high LDL cholesterol. Trends were assessed using annual percentage change (APC) in age-standardized mortality rate (ASMR), age-standardized DALYs rate (ASDR), and age-standardized years lived with disability (ASYLD) by Socio-demographic Index (SDI), sex, and location.</div></div><div><h3>Results</h3><div>From 1990 to 2021, global ASMR and ASDR attributable to high LDL cholesterol declined. In 2021, ASMR and ASDR were lowest in high SDI regions. Israel recorded the largest decrease in APC for both ASMR and ASDR, while Lesotho exhibited the highest increase. Over the same period, Singapore showed the greatest decline in APC of ASYLD, whereas Tanzania had the most pronounced increase. The greatest reductions in APC of ASMR and ASDR from 1990 to 2021 were observed in high SDI countries, particularly during the decade 2000–2010. Females consistently showed declining APCs of ASMR across all SDI quintiles, whereas in males, APCs declined only in high and high-middle SDI countries.</div></div><div><h3>Conclusion</h3><div>Persistent disparities in CVD burden attributable to high LDL across SDI quintiles highlight the need for equitable, tailored lipid-lowering and cardiometabolic prevention strategies.</div></div>","PeriodicalId":7868,"journal":{"name":"American heart journal","volume":"290 ","pages":"Pages 18-19"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Global Trends and Sociodemographic Disparities in LDL-Attributable Cardiovascular Disease: GBD 2021 Analysis (1990–2021)\",\"authors\":\"Rohan Raj , Ujjwal Mishra , Nikhil Jain , Kanishka Kumar Awasthi\",\"doi\":\"10.1016/j.ahj.2025.07.047\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Elevated low-density lipoprotein (LDL) cholesterol is a major modifiable risk factor for cardiovascular disease (CVD). While global trends in LDL-attributable CVD have been previously reported, disparities across sociodemographic development levels remain insufficiently explored.</div></div><div><h3>Objective</h3><div>To assess global, regional, and SDI-specific trends in the CVD burden attributable to high LDL cholesterol from 1990 to 2021.</div></div><div><h3>Methods</h3><div>We utilized Global Burden of Disease (GBD) 2021 data to evaluate CVD mortality and disability-adjusted life years (DALYs) attributable to high LDL cholesterol. Trends were assessed using annual percentage change (APC) in age-standardized mortality rate (ASMR), age-standardized DALYs rate (ASDR), and age-standardized years lived with disability (ASYLD) by Socio-demographic Index (SDI), sex, and location.</div></div><div><h3>Results</h3><div>From 1990 to 2021, global ASMR and ASDR attributable to high LDL cholesterol declined. In 2021, ASMR and ASDR were lowest in high SDI regions. Israel recorded the largest decrease in APC for both ASMR and ASDR, while Lesotho exhibited the highest increase. Over the same period, Singapore showed the greatest decline in APC of ASYLD, whereas Tanzania had the most pronounced increase. The greatest reductions in APC of ASMR and ASDR from 1990 to 2021 were observed in high SDI countries, particularly during the decade 2000–2010. Females consistently showed declining APCs of ASMR across all SDI quintiles, whereas in males, APCs declined only in high and high-middle SDI countries.</div></div><div><h3>Conclusion</h3><div>Persistent disparities in CVD burden attributable to high LDL across SDI quintiles highlight the need for equitable, tailored lipid-lowering and cardiometabolic prevention strategies.</div></div>\",\"PeriodicalId\":7868,\"journal\":{\"name\":\"American heart journal\",\"volume\":\"290 \",\"pages\":\"Pages 18-19\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American heart journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S000287032500256X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American heart journal","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S000287032500256X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Global Trends and Sociodemographic Disparities in LDL-Attributable Cardiovascular Disease: GBD 2021 Analysis (1990–2021)
Background
Elevated low-density lipoprotein (LDL) cholesterol is a major modifiable risk factor for cardiovascular disease (CVD). While global trends in LDL-attributable CVD have been previously reported, disparities across sociodemographic development levels remain insufficiently explored.
Objective
To assess global, regional, and SDI-specific trends in the CVD burden attributable to high LDL cholesterol from 1990 to 2021.
Methods
We utilized Global Burden of Disease (GBD) 2021 data to evaluate CVD mortality and disability-adjusted life years (DALYs) attributable to high LDL cholesterol. Trends were assessed using annual percentage change (APC) in age-standardized mortality rate (ASMR), age-standardized DALYs rate (ASDR), and age-standardized years lived with disability (ASYLD) by Socio-demographic Index (SDI), sex, and location.
Results
From 1990 to 2021, global ASMR and ASDR attributable to high LDL cholesterol declined. In 2021, ASMR and ASDR were lowest in high SDI regions. Israel recorded the largest decrease in APC for both ASMR and ASDR, while Lesotho exhibited the highest increase. Over the same period, Singapore showed the greatest decline in APC of ASYLD, whereas Tanzania had the most pronounced increase. The greatest reductions in APC of ASMR and ASDR from 1990 to 2021 were observed in high SDI countries, particularly during the decade 2000–2010. Females consistently showed declining APCs of ASMR across all SDI quintiles, whereas in males, APCs declined only in high and high-middle SDI countries.
Conclusion
Persistent disparities in CVD burden attributable to high LDL across SDI quintiles highlight the need for equitable, tailored lipid-lowering and cardiometabolic prevention strategies.
期刊介绍:
The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.